FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1534811000001107: Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24393901000001117 Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37939701000001114 Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Is a Lisinopril 20mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Is pack of Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) false Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Has active ingredient Lisinopril false Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Has AMP Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) true Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Has specific active ingredient Lisinopril true Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Carace 20mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start